✦ LIBER ✦

Feasibility, Safety and Efficacy of Maraviroc, a CCR5 Antagonist, in Graft-Versus-Host Disease Prevention After Reduced intensity Conditioned (RIC) Allogeneic Stem Cell Transplant (SCT): a Phase I/II Study

✍ Scribed by R. Reshef; S.M. Luger; A.W. Loren; N.V. Frey; S.C. Goldstein; E.O. Hexner; E.A. Stadtmauer; J. Smith; R. Mick; D.F. Heitjan; J.A. Hoxie; S.G. Emerson; R.H. Vonderheide; D.L. Porter

Book ID: 116282467
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 50 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Prospective Phase I/II Trial of Bortez

A Prospective Phase I/II Trial of Bortezomib-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Encouraging Safety, Efficacy, and Survival

✍ J. Koreth; K.E. Stevenson; H.T. Kim; B. Bindra; S. McDonough; V.T. Ho; C.S. Cutl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 83 KB

A Phase I/II Study of Mycophenolate Mofe

A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation

✍ Richard A. Nash; Laura Johnston; Pablo Parker; Jeannine S. McCune; Barry Storer; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A Phase I/II study of the safety and eff

A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)

✍ Michael A. Pulsipher; Donna A. Wall; Michael Grimley; Rakesh K. Goyal; Kenneth M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB